AI Article Synopsis

  • Iron deficiency anemia (IDA) is a significant global health issue, highlighting the need for new iron fortificants with high bioavailability and minimal impact on food properties.
  • The study involved creating BSA-Fe nanoparticles using a one-pot reduction method and comparing their effectiveness and safety to traditional iron supplements like FeSO4 through various assays.
  • Results show that BSA-Fe nanoparticles are small, water-soluble, and biocompatible, demonstrating similar bioavailability to FeSO4, suggesting they could be promising candidates for clinical use in treating IDA.

Article Abstract

BACKGROUND Iron deficiency anemia (IDA) has been a major public health problem all over the world. Developing new iron (Fe) fortificants with both high bioavailability and negligible food sensory changes for IDA is in urgent demand. MATERIAL AND METHODS The Fe nanoparticles were fabricated through a one-pot reduction process under the protection of bovine serum albumin (BSA). The BSA-Fe nanoparticles were characterized systematically. The comparisons between BSA-Fe nanoparticles and FeSO4 in bioavailability were carried out through hemoglobin (Hb) repletion method. The biocompatibility of BSA-Fe nanoparticles was also investigated through in vitro and in vivo assays. RESULTS BSA-Fe nanoparticles have super-small size and good water solubility as well as water stability. The Hb repletion assay demonstrated that BSA-Fe nanoparticles have comparative bioavailability with FeSO4. The in vitro cell viability assay, in vivo histological analysis, and biochemical measurements proved the remarkable biocompatibility of BSA-Fe nanoparticles. CONCLUSIONS The BSA-Fe nanoparticles fabricated through a one-pot facile method have good water solubility, comparative bioavailability with FeSO4, and acceptable biocompatibility, exhibiting good potential for further clinical translations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6151109PMC
http://dx.doi.org/10.12659/MSM.909591DOI Listing

Publication Analysis

Top Keywords

bsa-fe nanoparticles
28
nanoparticles
9
one-pot facile
8
nanoparticles fabricated
8
fabricated one-pot
8
biocompatibility bsa-fe
8
good water
8
water solubility
8
comparative bioavailability
8
bioavailability feso4
8

Similar Publications

Europium nanospheres based ultrasensitive fluorescence immunosensor for aflatoxin B1 determination in feed.

Talanta

April 2024

Oil Crops Research Institute, Chinese Academy of Agricultural Sciences, Wuhan, 430062, China; Key Laboratory of Biology and Genetic Improvement of Oil Crops, Ministry of Agriculture and Rural Affairs, Wuhan, 430062, China; National Reference Laboratory for Agricultural Testing (Biotoxin), Wuhan, 430062, China; Key Laboratory of Detection for Mycotoxins, Ministry of Agriculture and Rural Affairs, Wuhan, 430062, China; Laboratory of Quality and Safety Risk Assessment for Oilseed Products (Wuhan), Ministry of Agriculture and Rural Affairs, Wuhan, 430062, China. Electronic address:

In this work, a new competitive immunosensor for aflatoxin B1 (AFB1) detection was developed using europium (Eu) fluorescent nanospheres and magnetic beads. Firstly, Eu nanospheres were synthesized through two steps including carboxylated polystyrene nanospheres and Eu-doped polystyrene nanospheres preparation. Then Eu nanospheres were covalently tagged to anti-AFB1 monoclonal antibody (anti-AFB1 mAb) through an EDC coupling method.

View Article and Find Full Text PDF

Purpose: In recent years, the use of nanoparticles has been developed to improve MRI contrast. To improve the contrast agents in image-guided therapy by Multifunctional nanoparticles, in this study, we synthesized a theranostic magneto-plasmonic nanocomplex based on magnetic iron oxide nanoparticles and bovine serum albumin-modified gold nanorod (Au@BSA-Fe3O4@CMD). The purpose of synthesizing these nanoparticles was to use them as MRI contrast agent and photothermal agents in in vitro and in vivo experiments.

View Article and Find Full Text PDF

Janus heterostructures based on bimetallic nanoparticles have emerged as effective radiosensitizers owing to their radiosensitization capabilities in cancer cells. In this context, this study aims at developing a novel bimetallic nanoradiosensitizer, BiS-FeO, to enhance tumor accumulation and promote radiation-induced DNA damage while reducing adverse effects. Due to the presence of both iron oxide and bismuth sulfide metallic nanoparticles in these newly developed nanoparticle, strong radiosensitizing capacity is anticipated through the generation of reactive oxygen species (ROS) to induce DNA damage under X-Ray irradiation.

View Article and Find Full Text PDF

Overexpression of epidermal growth factor receptor (EGFR) is closely associated with a poor prognosis in non-small cell lung cancer (NSCLC), thus making it a promising biomarker for NSCLC diagnosis. Here, we conjugated a single-chain antibody (scFv) targeting EGFR with FeO/Au nanoparticles to form an EGFR-specific molecular MRI bioprobe (scFv@FeO/Au) to better detect EGFR-positive NSCLC tumors in vivo. In vitro, we demonstrated that the EGFR-specific scFv could specifically deliver FeO/Au to EGFR-positive NSCLC cells.

View Article and Find Full Text PDF

Alternariol monomethyl ether (AME) is one of the major Alternaria mycotoxins present in a wide range of fruits, vegetables, grains, and their products, and possesses the properties of mutagenicity and carcinogenicity. In this study, a simple, rapid, and highly sensitive colorimetric immunosensor based on magnetic nanoparticles (MNPs) was firstly developed for the detection of AME in fruit by nonaggregated gold nanoparticles (GNPs). AME-BSA-FeO MNP conjugates and free AME molecules in samples competitively bind with monoclonal antibody (mAb)-GNP conjugates.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!